The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Whither trial‐based economic evaluation for health care decision making?
Abstract
The randomised controlled trial (RCT) has developed a central role in applied cost‐effectiveness studies in health care as the vehicle for analysis. This paper considers the role of trial‐based economic evaluation in this era of explicit decision making. It is argued that any framework for economic analysis can only be judged insofar as it can inform two key decisions and be consistent with the objectives of a health care system subject to its resource constraints. The two decisions are, firstly, whether to adopt a health technology given existing evidence and, secondly, an assessment of whether more evidence is required to support this decision in the future. It is argued that a framework of economic analysis is needed which can estimate costs and effects, based on all the available evidence, relating to the full range of possible alternative interventions and clinical strategies, over an appropriate time horizon and for specific patient groups. It must also enable the accumulated evidence to be synthesised in an explicit and transparent way in order to fully represent the decision uncertainty. These requirements suggest that, in most circumstances, the use of a single RCT as a vehicle for economic analysis will be an inadequate and partial basis for decision making. It is argued that RCT evidence, with or without economic content, should be viewed as simply one of the sources of evidence, which must be placed in a broader framework of evidence synthesis and decision analysis. Copyright © 2006 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence based medicine: what it is and what it isn't
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996) · BMJ · doi:10.1136/bmj.312.7023.71 · Cited by 15,769
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-825_9 · Cited by 3,476
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Self-citationClinical Epidemiology: A Basic Science for Clinical Medicine.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-874_2 · Cited by 779
Bayesian methods in meta-analysis and evidence synthesis
Sutton, A. J., & Abrams, K. R. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000404 · Cited by 710
Philips, Z., Ginnelly, L., Sculpher, M., Claxton, K., Golder, S., Riemsma, R., Woolacoot, N., & Glanville, J. (2004) · Health Technology Assessment · doi:10.3310/hta8360 · Cited by 697
Self-citationBORROWING STRENGTH FROM EXTERNAL TRIALS IN A META-ANALYSIS
HIGGINS, J. P. T., & WHITEHEAD, A. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961230)15:24<2733::aid-sim562>3.0.co;2-0 · Cited by 557
Mark, D. B., Hlatky, M. A., Califf, R. M., Naylor, C. D., Lee, K. L., Armstrong, P. W., Barbash, G., White, H., Simoons, M. L., Nelson, C. L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322106 · Cited by 521
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
Claxton, K., Sculpher, M., McCabe, C., Briggs, A., Akehurst, R., Buxton, M., Brazier, J., & O'Hagan, T. (2005) · Health Economics · doi:10.1002/hec.985 · Cited by 472
Self-citationA rational framework for decision making by the National Institute for Clinical Excellence (NICE)
Claxton, K., Sculpher, M., & Drummond, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09832-x · Cited by 456
Self-citationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE): HTA Rhyme and Reason?
Taylor, R. (2002) · International Journal of Technology Assessment in Health Care · doi:10.1017/s026646230200017x · Cited by 411
An economic approach to clinical trial design and research priority-setting
Claxton, K., & Posnett, J. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9 · Cited by 395
Self-citationExpected Value of Sample Information Calculations in Medical Decision Modeling
Ades, A. E., Lu, G., & Claxton, K. (2004) · Medical Decision Making · doi:10.1177/0272989x04263162 · Cited by 364
Self-citationHealth Economic Guidelines—Similarities, Differences and Some Implications
Hjelmgren, J., Berggren, F., & Andersson, F. (2001) · Value in Health · doi:10.1046/j.1524-4733.2001.43040.x · Cited by 322
Modelling in the economic evaluation of health care: selecting the appropriate approach
Barton, P., Bryan, S., & Robinson, S. (2004) · Journal of Health Services Research & Policy · doi:10.1258/135581904322987535 · Cited by 291
Meta-analysis of multiple outcomes by regression with random effects
Berkey, C. S., Hoaglin, D. C., Antczak-Bouckoms, A., Mosteller, F., & Colditz, G. A. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981130)17:22<2537::aid-sim953>3.0.co;2-c · Cited by 280
Claxton, K., Ginnelly, L., Sculpher, M., Philips, Z., & Palmer, S. (2004) · Health Technology Assessment · doi:10.3310/hta8310 · Cited by 258
Self-citationThe Journal's Policy on Cost-Effectiveness Analyses
Kassirer, J. P., & Angell, M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311009 · Cited by 233
How to develop cost-conscious guidelines
Eccles, M., & Mason, J. (2001) · Health Technology Assessment · doi:10.3310/hta5160 · Cited by 211
The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment
Sculpher, M., Drummond, M., & Buxton, M. (1997) · Journal of Health Services Research & Policy · doi:10.1177/135581969700200107 · Cited by 208
Self-citationProblems of using modelling in the economic evaluation of health care
Sheldon, T. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199601)5:1<1::aid-hec183>3.0.co;2-k · Cited by 164
Lay public's understanding of equipoise and randomisation in randomised controlled trials
Robinson, E., Kerr, C., Stevens, A. J., Lilford, R. J., Braunholtz, D., Edwards, S., Beck, S. R., & Rowley, M. (2005) · Health Technology Assessment · doi:10.3310/hta9080 · Cited by 151
Samsa, G. P., Reutter, R. A., Parmigiani, G., Ancukiewicz, M., Abrahamse, P., Lipscomb, J., & Matchar, D. B. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00151-6 · Cited by 140
Ades, A. E. (2003) · Statistics in Medicine · doi:10.1002/sim.1566 · Cited by 131
Manca, A., Rice, N., Sculpher, M. J., & Briggs, A. H. (2004) · Health Economics · doi:10.1002/hec.914 · Cited by 117
Self-citationAdes, A. E., & Cliffe, S. (2002) · Medical Decision Making · doi:10.1177/027298902400448920 · Cited by 104
Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach
Cooper, N. J., Sutton, A. J., Abrams, K. R., Turner, D., & Wailoo, A. (2003) · Health Economics · doi:10.1002/hec.804 · Cited by 103
The Advanced Handbook of Methods in Evidence Based Healthcare
Stevens, A. J., Abrams, K., Brazier, J. E., Fitzpatrick, R. M., & Lilford, R. J. (2001) · SAGE Publications Ltd eBooks · doi:10.4135/9781848608344 · Cited by 88
Using multilevel models for assessing the variability of multinational resource use and cost data
Grieve, R., Nixon, R. M., Thompson, S. G., & Normand, C. E. M. (2004) · Health Economics · doi:10.1002/hec.916 · Cited by 77
Pragmatic Versus Explanatory Trials
MacRae, K. D. (1989) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300007406 · Cited by 54
Health Policy and Economics: Opportunities and Challenges
Smith, P., Ginnelly, L., & Schlpher, M. (2004) · Cited by 52
Willan, A. R., Pinto, E. M., OʼBrien, B. J., Kaul, P., Goeree, R. A., Lynd, L. D., & Armstrong, P. W. (2005) · Health Economics · doi:10.1002/hec.969 · Cited by 45
Owens, D. K., & Nease, R. F. (1997) · Medical Decision Making · doi:10.1177/0272989x9701700406 · Cited by 43
Fenwick, E., Claxton, K., Sculpher, M., & Briggs, A. H. (2000) · RePEc: Research Papers in Economics · Cited by 41
Self-citationRobinson, M., Palmer, S., Sculpher, M., Philips, Z., Ginnelly, L., Bowens, A., Golder, S., Alfakih, K., Bakhai, A., Packham, C., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9270 · Cited by 36
Self-citationSculpher, M. J., Poole, L., Cleland, J. G. F., Drummond, M., Armstrong, P. W., Horowitz, J. D., Massie, B. M., Poole-Wilson, P. A., & Rydén, L. (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00122-7 · Cited by 33
Self-citationRobinson, M., Ginnelly, L., Sculpher, M., Jones, L., Riemsma, R. P., Palmer, S., Phillips, Z., & Glanville, J. (2002) · Health Technology Assessment · doi:10.3310/hta6250 · Cited by 26
Self-citation
Cited by
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
Self-citationRamsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
Drummond, M., Barbieri, M., Cook, J., Glick, H. A., Lis, J., Malik, F., Reed, S. D., Rutten, F., Sculpher, M., & Severens, J. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00489.x · Cited by 533
Self-citationHiligsmann, M., Cooper, C., Arden, N., Boers, M., Branco, J. C., Luisa Brandi, M., Bruyère, O., Guillemin, F., Hochberg, M. C., Hunter, D. J., et al. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.07.003 · Cited by 327
Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
Petrou, S., & Gray, A. (2011) · BMJ · doi:10.1136/bmj.d1548 · Cited by 318
Metadata
- Authors
- Sculpher, M. J., Claxton, K., Drummond, M., & McCabe, C.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2006-02-20
- Volume
- 15
- Issue
- 7
- Pages
- 677-687
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2145371590
- Cited by
- 407
- References
- 38
- FWCI
- 49.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.